OncoSenX, Inc. — Form D/A
OncoSenX, Inc. of SEATTLE, WA, a company, filed a Form D amendment with the SEC on 2020-04-30. The offering totals $5.5M, of which $4.1M was reported sold. Industry: Other.
Offering
- Filed: 2020-04-30
- Form: D/A
- Accession: 0001780610-20-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $5.5M
- Amount sold: $4.1M
- Remaining: $1.4M
- Investors: 62
- Date of first sale: 2017-12-22
- Revenue range: Decline to Disclose
- SEC file number: 021-343617
Issuer
- Name: OncoSenX, Inc.
- CIK: 0001780610
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 701 Fifth Avenue, SEATTLE, WA, 98104
- Phone: 206-880-1166
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| John Lewis | Director | Gibsonia, PA |
| John Lewis | Executive Officer | Gibsonia, PA |
| John Lewis | Promoter | Gibsonia, PA |
| Eric Garcia | Executive Officer | Seattle, WA |
| Matthew Scholz | Director | Seattle, WA |
| Matthew Scholz | Executive Officer | Seattle, WA |
| Matthew Scholz | Promoter | Seattle, WA |
| Stephen Hilbert | Executive Officer | Seattle, WA |
| Gary Hudson | Director | Seattle, WA |
| Gary Hudson | Executive Officer | Seattle, WA |
| Gary Hudson | Promoter | Seattle, WA |
Other filings by this issuer (2)
More